CTLA4 and neoplasm: Although anti-CTLA-4 is not prominent in immunotherapy as a monotherapy, it is being clinically tested in a variety of cancers as an effective means of enhancing anti-tumor response when applied with other therapies, such as chemotherapy and radiotherapy.